Medline Inc. (MDLN) Q3 2026 earnings results
Medline Inc. (MDLN) reported Q3 2026 results on Nov 4, 2026, 7:30:00 AM ET: adjusted EPS $0.44 vs. $0.35 expected (beat by 27.1%); revenue $7.90B vs. $7.72B expected (beat by 2.3%). Outlook: Full year 2026 Organic Sales growth outlook raised to 10.0% to 10.5% and Adjusted EBITDA reaffirmed at $3.3 billion to $3.4 billion.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $0.44 | $0.35 | Beat by 27.1% |
| Revenue | $7.90B | $7.72B | Beat by 2.3% |
Analyst estimate: the average forecast before the release.
Source
Figures from the Press release, released Nov 4, 2026, 7:30:00 AM ET. Nexqual published them 11 min 29 s after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 27, 2025, from the company's SEC filing): revenue grew 11.0% from $7.12B.
Stock reaction
The results came out before the market opened. MDLN closed at $40.35 on November 4, 2026, up 18.4% from its $34.09 close on November 3, 2026 before the results. Latest: $40.76 as of 11:53 AM ET, +19.6% since the pre-release close.
Questions and answers
Did Medline Inc. beat earnings expectations?
Yes. Medline Inc. reported adjusted EPS of $0.44 against an average analyst estimate of $0.35 (beat by 27.1%), and revenue of $7.90B against $7.72B expected (beat by 2.3%).
What were Medline Inc.'s Q3 2026 earnings and revenue?
adjusted diluted EPS of $0.44 and revenue of $7.90B. Compared with the same quarter a year earlier (ended September 27, 2025, from the company's SEC filing): revenue grew 11.0% from $7.12B.
When did Medline Inc. report Q3 2026 earnings?
Nov 4, 2026, 7:30:00 AM ET, in a company press release.
How did MDLN stock react to the earnings?
The results came out before the market opened. MDLN closed at $40.35 on November 4, 2026, up 18.4% from its $34.09 close on November 3, 2026 before the results. Latest: $40.76 as of 11:53 AM ET, +19.6% since the pre-release close.
What did Medline Inc. say about its outlook?
Full year 2026 Organic Sales growth outlook raised to 10.0% to 10.5% and Adjusted EBITDA reaffirmed at $3.3 billion to $3.4 billion.
More on MDLN
MDLN stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 4, 2026.
Source: company earnings press release, Nexqual Earnings Flash. Built November 10, 2026 at 16:53 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt